Newsroom

Takeda Corporate Information

To learn about our parent company, Takeda Pharmaceutical Company Limited, please visit http://www.takeda.com/

Media Inquiries

For media inquiries or reporter requests for more information, contact our Corporate Communications via [email protected]. If you generally would like to contact us, please visit Contact Us.

Recent News Releases

April 11th, 202304/11/2023

Takeda Receives FDA Approval to Expand the Use of HYQVIA^® to Treat Primary Immunodeficiency in Children

April 3rd, 202304/03/2023

Takeda Announces New U.S. Corporate Social Responsibility (CSR) Program Partners

October 5th, 202210/05/2022

U.S. Food and Drug Administration Accepts Takeda’s Supplemental Biologics License Application for Use of TAKHZYRO^® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older

September 14th, 202209/14/2022

Takeda Launches CDPATH™, a Personalized Prognostic Tool, Advancing Innovation for Patients with Crohn’s Disease

June 22nd, 202206/22/2022

Takeda Announces Creation of One Cambridge Campus in Kendall Square to Drive Innovation Efforts

SEE ALL NEWS AND RELEASES >